Products

Cas No.Product NameDescription
1346704-33-3GSK343GSK343 is a specific inhibitor of EZH2 methyltransferase, which can decrease the level of H3K27Me3, the product of EZH2's enzymatic activity.
139481-59-7Candesartan Candesartan is an angiotensin II receptor antagonist with an IC50 of 15 μg/kg.
120511-73-1AnastrozoleAnastrozole is a third-generation nonsteroidal selective aromatase inhibitor.
90357-06-5BicalutamideBicalutamide is an androgen receptor (AR) antagonist with IC50 of 0.16 μM.
53-43-0DHEADehydroepiandrosterone(DHEA) is a 19-carbon endogenous natural steroid hormone.
50-41-9Clomifene citrateClomifene Citrate is a selective estrogen receptor modulator.
129453-61-8Fulvestrant Fulvestrant is an estrogen receptor (ER) antagonist with IC50 of 0.94 nM.
84-16-2HexestrolHexestrol binds to ERα and ERβ with EC50 of 0.07 nM and 0.175 nM, respectively.
54965-24-1Tamoxifen citrateTamoxifen is an antagonist of the estrogen receptor in breast tissue via its active metabolite, hydroxytamoxifen.
147098-20-2Rosuvastatin CalciumRosuvastatin Calcium is a competitive inhibitor of HMG-CoA reductase with IC50 of 11 nM.
52-76-6Lynestrenol
79517-01-4;83150-76-9 (net) Octreotide acetateOctreotide acetate(SMS 201995 acetate) is a long-acting octapeptide with pharmacologic actions mimicking those of the natural hormone somatostatin.
68392-35-8Afimoxifene4-Hydroxytamoxifen is the active metabolite of tamoxifen and a selective estrogen receptor (ER) modulator that is widely used in the therapeutic and chemopreventive treatment of breast cancer.
265121-04-8Fosaprepitant Fosaprepitant (also known as MK-0517 and L-758,298) is a water-soluble phosphoryl prodrug for aprepitant
144689-63-4CS-866Olmesartan medoxomil(Olmetec; Benicar; CS 866) is an angiotensin II receptor antagonist which is used as an anti-hypertensive.
7280-37-7Estropipate
172673-20-0FosaprepitantFosaprepitant (MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
956104-40-8ARN-509;ApalutamideARN-509 is a selective and competitive androgen receptor inhibitor with IC50 of 16 nM, useful for prostate cancer treatment.
57-41-0PhenytoinPhenytoin is an inactive voltage-gated sodium channel stabilizer.
1165910-22-4LGD-4033 LGD-4033 is a selective androgen receptor modulator a novel non-steroidal

First Previous Next End   Jump to  Page
PI3K/Akt/mTOR
Cell Cycle/Checkpoint
Angiogenesis/Tyrosine Kinase
Apoptosis Pathway
PARP/BET
Aurora/Ksp Pathway
MAPK Pathway
Hormone Pathay
Integrase/CCR5
Proteases/HSP90/HSP70 Pathway
Wnt/Hedgehog/Notch Pathway
Jak/Stat Pathway
Ca/cAMP/Lipid Signaling Pathway
Neuro Signaling Pathway
TGF-beta/Smad Signaling Pathway
GPCR Pathway
Ion channel Pathway
Cytochrome P450 Pathway
Others Pathway
Intermediate